This week, one of my patient advocacy highlights was to be part of an esteemed panel on an extremely important topic on “Impact of Patient Advocacy in Modern Healthcare Delivery Mechanisms” at the IHW Council event of ‘Patient First Summit & Awards 2022‘.
It was a great discussion to share with established and budding patient support groups & advocates who have attended this event on – how patient advocacy has potential to move mountains, how it is already changing the face of India healthcare system for better and why we need more patient advocacy in India. And top of that, awarding those amazing patient advocates/ advocacy groups, who are selflessly serving patients in India.
I am honored to contribute along with world leading experts on this extremely important 𝐩𝐚𝐩𝐞𝐫 on 𝐂𝐚𝐧𝐜𝐞𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 in 𝐋𝐌𝐈𝐂𝐬 which got published in one the world’s top journal “𝐍𝐚𝐭𝐮𝐫𝐞 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 (impact factor: 53.44)”. I have co-authored this paper along with: – Tata Memorial Centre, Homi Bhabha National Institute, India, – The Chief Scientist of WHO – and Scientists and leading experts from: > National Cancer Institute (NCI), USA > University of Oxford, England > University of Harvard, USA > King’s College London, > Queen’s University, Canada > University of Toronto, > University of North Carolina, USA > National Cancer Institute of Sri Lanka. > and scientists, researchers and oncologists from Turkey, Nepal, Kenya, Uganda, Malaysia, Ghana and France
This perspective paper is expected to be the 𝐠𝐮𝐢𝐝𝐢𝐧𝐠 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭 in 𝐩𝐨𝐥𝐢𝐜𝐲 𝐦𝐚𝐤𝐢𝐧𝐠 as path forward for Cancer Research globally, including with LMICs.
I, being the only patient advocate across the globe, as part of this initiative – it was great opportunity to work with best of minds and world leading experts for better future of our patients and cancer research, globally.
Snapshot of the article is attached and link of the full article is as https://www.nature.com/articles/s41591-022-01738-x . Hope you connect with this article and be part of this initiative so no one (including in LMICs) left alone and everyone has access and benefits of Cancer research.